Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Epizyme beat estimated earnings by 41.67%, reporting an EPS of $-0.21 versus an estimate of $-0.36.
Revenue was up $14.52 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 21.16% drop in the share price the next day.
Here's a look at Epizyme's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.35 | -0.45 | -0.48 | -0.62 |
EPS Actual | -0.38 | -0.49 | -0.64 | -0.63 |
Revenue Estimate | 10.42M | 18.63M | 13.18M | 8.72M |
Revenue Actual | 8.70M | 11.58M | 5.20M | 13.01M |
To track all earnings releases for Epizyme visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.